Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous cytokine induced killer cells (2 trials)
bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (1 trial)
cisplatin (platinol) (1 trial)
carboplatin (paraplatin) (1 trial)
icotinib (Conmana) (1 trial)
pemetrexed (alimta) (1 trial)
prednisone (meticorten) (1 trial)
Carcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Lung Neoplasms (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Poliomyelitis (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Trials (6 total)
Trial APIs (7 total)